146 related articles for article (PubMed ID: 3878943)
21. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
Condiotti R; Nagler A
Exp Hematol; 1998 Jul; 26(7):571-9. PubMed ID: 9657131
[TBL] [Abstract][Full Text] [Related]
22. In vitro enhancement of peripheral blood mononuclear cell natural killer activity following short term incubation with fetal calf serum.
Lauer SJ; Finlan J; Borella LD; Piaskowski VD; Casper JT
J Clin Lab Immunol; 1983 Oct; 12(2):105-10. PubMed ID: 6606047
[TBL] [Abstract][Full Text] [Related]
23. A novel type of human T cell clone with highly potent natural killer-like cytotoxicity divorced from large granular lymphocyte morphology.
Schneider EM; Pawelec GP; Liangru S; Wernet P
J Immunol; 1984 Jul; 133(1):173-9. PubMed ID: 6609974
[TBL] [Abstract][Full Text] [Related]
24. Natural killer cells kill human retinoblastoma cells.
Ohashi Y; Sasabe T; Nishida T; Manabe R
Jpn J Ophthalmol; 1984; 28(4):370-6. PubMed ID: 6085129
[TBL] [Abstract][Full Text] [Related]
25. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
26. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
Burns GF; Triglia T; Werkmeister JA
J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
[TBL] [Abstract][Full Text] [Related]
27. An exoglycosidase-sensitive triggering site on NK cells which is coupled to transmethylation of membrane phospholipids.
Kiyohara T; Dennis JW; Boegman RJ; Roder JC
J Immunol; 1985 Jul; 135(1):659-64. PubMed ID: 3923114
[TBL] [Abstract][Full Text] [Related]
28. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B
J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
[TBL] [Abstract][Full Text] [Related]
29. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.
Miller JS; Tessmer-Tuck J; Pierson BA; Weisdorf D; McGlave P; Blazar BR; Katsanis E; Verfaillie C; Lebkowski J; Radford J; Burns LJ
Biol Blood Marrow Transplant; 1997 Apr; 3(1):34-44. PubMed ID: 9209739
[TBL] [Abstract][Full Text] [Related]
30. Characterization of rhesus macaque natural killer activity against a rhesus-derived target cell line at the single-cell level.
Andersen H; Rossio JL; Coalter V; Poore B; Martin MP; Carrington M; Lifson JD
Cell Immunol; 2004; 231(1-2):85-95. PubMed ID: 15919373
[TBL] [Abstract][Full Text] [Related]
31. Effects of X-ray irradiation on natural killer (NK) cell system. I. Elevation of sensitivity of tumor cells and lytic function of NK cells.
Uchida A; Mizutani Y; Nagamuta M; Ikenaga M
Immunopharmacol Immunotoxicol; 1989; 11(2-3):507-19. PubMed ID: 2482851
[TBL] [Abstract][Full Text] [Related]
32. Large granular lymphocytes are central cells in the interleukin-2-dependent differentiation pathway of natural killer cells.
Lange A; Ernst M; Jaźwiec B; Ennen J; Flad HD
Nat Immun Cell Growth Regul; 1987; 6(5):237-49. PubMed ID: 3502170
[TBL] [Abstract][Full Text] [Related]
33. Prostaglandin E2-induced changes in the phenotype, morphology, and lytic activity of IL-2-activated natural killer cells.
Linnemeyer PA; Pollack SB
J Immunol; 1993 May; 150(9):3747-54. PubMed ID: 8386202
[TBL] [Abstract][Full Text] [Related]
34. Endogenous IL-2 production by natural killer cells maintains cytotoxic and proliferative capacity following retroviral-mediated gene transfer.
Miller JS; Tessmer-Tuck J; Blake N; Lund J; Scott A; Blazar BR; Orchard PJ
Exp Hematol; 1997 Oct; 25(11):1140-8. PubMed ID: 9328450
[TBL] [Abstract][Full Text] [Related]
35. Augmentation of human natural killer cell activity by cyclophosphamide in vitro.
Sharma B; Vaziri ND
Cancer Res; 1984 Aug; 44(8):3258-61. PubMed ID: 6589041
[TBL] [Abstract][Full Text] [Related]
36. Chemotactic effect of human recombinant interleukin 2 on mouse activated large granular lymphocytes.
Natuk RJ; Welsh RM
J Immunol; 1987 Oct; 139(8):2737-43. PubMed ID: 3498769
[TBL] [Abstract][Full Text] [Related]
37. Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.
Suthanthiran M; Williams PS; Solomon SD; Rubin AL; Stenzel KH
J Clin Invest; 1984 Dec; 74(6):2263-71. PubMed ID: 6392343
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
Gan X; Zhang L; Solomon GF; Bonavida B
Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
[TBL] [Abstract][Full Text] [Related]
39. Natural killer (NK) cell activity in the rat. I. Isolation and characterization of the effector cells.
Reynolds CW; Timonen T; Herberman RB
J Immunol; 1981 Jul; 127(1):282-7. PubMed ID: 7240744
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of human NK clones: target specificity and phenotype.
Allavena P; Ortaldo JR
J Immunol; 1984 May; 132(5):2363-9. PubMed ID: 6201541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
